Certific aims to transform healthcare through eliminating unnecessary appointments with trusted remote diagnostics for millions of people. The platform radically improves the cost and convenience for patients, healthcare providers and national healthcare services alike. Certific has served patients to self test over 100,000 times and was the first to launch fully certified remote Covid testing in the UK and Estonia. They recently launched UTI (urinary tract infection) and STI (sexually transmitted infections) remote testing services in UK and Europe. The funding will enable Certific to expand to new markets and evolve its product offering.
Working with leading organisations like Imperial College London, Tartu University in Estonia and other independent, internationally-recognised academic institutions to validate its processes and professional standards, Certific is creating a global standard for clinical grade at-home procedures.
Plural, which led the seed funding, is a €250m investment platform set up by four leading European founders to invest in the founders of the next generation of European technology. Plural’s investors are seeking to solve hard problems with technology, and have identified expanding access to healthcare and improving healthcare as two areas where innovation can make a significant impact.
Other investors include Specialist VC which is a venture capital fund created to support forward-thinking founders from Estonia, Latvia, Lithuania, Finland and Ukraine, and among other angel investors, Christopher North, former UK Managing Director of Amazon.
Certific improves patient experiences by providing technology and medical expertise that enables self-testing and screening programmes at scale, encouraging high participation rates and therefore capable of catching illnesses earlier.